# OnCo record second-primary-breast-after-chest-radiotherapy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/second-primary-breast-after-chest-radiotherapy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "second-primary-breast-after-chest-radiotherapy" ;
  schema:name "Breast cancer after chest radiotherapy given young"@en ;
  schema:alternateName "Breast cancer after Hodgkin lymphoma"@en, "Breast cancer after mantle radiotherapy"@en, "Radiation-related breast cancer"@en ;
  schema:description "This is the second cancer with a real screening programme attached, and the one most worth asking about by name. A woman who had radiotherapy to breast tissue between the ages of 10 and 35, most often for Hodgkin lymphoma, is eligible in England for annual magnetic resonance imaging from age 25 or 30, and being missed from that list has happened often enough that asking is reasonable."@en ;
  schema:url <https://onco.cc/terms/second-primary-breast-after-chest-radiotherapy/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Radiation-induced_cancer> ;
  schema:citation <https://doi.org/10.1001/jama.290.4.465>, <https://doi.org/10.1093/jnci/dji290>, <https://www.gov.uk/government/publications/breast-screening-higher-risk-women-surveillance-protocols/tests-and-frequency-of-testing-for-women-at-very-high-risk--2>, <https://www.gov.uk/government/publications/breast-screening-higher-risk-women-surveillance-protocols/protocols-for-surveillance-of-women-at-higher-risk-of-developing-breast-cancer> ;
  onco:tag "rejuvenation", "survivorship", "second-cancers", "breast", "radiotherapy", "screening" ;
  onco:related <https://onco.cc/terms/rejuv-second-uk-very-high-risk-breast-screening/>, <https://onco.cc/terms/rejuv-second-screening-after-treatment-compared/>, <https://onco.cc/terms/rejuv-second-radiotherapy-dose-field-and-age/>, <https://onco.cc/terms/rejuv-second-cancers-overview/> ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/mammography/>, <https://onco.cc/technologies/survivorship-care-plan/> ;
  onco:terms <https://onco.cc/terms/lymphoma-living-hodgkin-survivorship-screening/>, <https://onco.cc/terms/lymphoma-tx-hodgkin-late-effects/>, <https://onco.cc/terms/secondary-malignancy/>, <https://onco.cc/terms/second-cancers-after-radiotherapy/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-care-fragmentation/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-schaapveld-second-cancer-risk-40-years-hodgkin-nejm-2015/> .